scholarly journals Clostridioides difficile Prevalence in the United States: National Inpatient Sample, 2016 to 2018

2021 ◽  
Author(s):  
Molly Petersen ◽  
Sara E Cosgrove ◽  
Eili Y Klein ◽  
Xianming Zhu ◽  
Thomas C Quinn ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Geographic Region ◽  
National Inpatient Sample ◽  
Hospital Discharges ◽  
Clostridioides Difficile

Abstract Data from the National Inpatient Sample indicate that Clostridioides difficile prevalence decreased from 10.3 (95%CI=10.1-10.5) to 8.7 (95%CI=8.5-8.8) per 1000 hospital discharges between 2016 and 2018, after accounting for age, sex, and race. There was heterogeneity in the prevalence and decrease in prevalence by geographic region in the United States.

scholarly journals Trends and Outcomes of Malignant Hyperthermia in the United States, 2000 to 2005

2009 ◽  
Vol 110 (1) ◽  
pp. 89-94 ◽  
Author(s):  
Eric B. Rosero ◽  
Adebola O. Adesanya ◽  
Carlos H. Timaran ◽  
Girish P. Joshi
Keyword(s):  
United States ◽  
Logistic Regression ◽  
Hospital Mortality ◽  
Malignant Hyperthermia ◽  
Survey Design ◽  
The United States ◽  
Geographic Region ◽  
Regression Analyses ◽  
Hospital Discharges ◽  
Comorbidity Burden

Background Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder with an estimated mortality of less than 5%. The purpose of this study was to evaluate the current incidence of MH and the predictors associated with in-hospital mortality in the United States. Methods The Nationwide Inpatient Sample, which is the largest all-payer inpatient database in the United States, was used to identify patients discharged with a diagnosis of MH during the years 2000-2005. The weighted exact Cochrane-Armitage test and multivariate logistic regression analyses were used to assess trends in the incidence and risk-adjusted mortality from MH, taking into account the complex survey design. Results From 2000 to 2005, the number of cases of MH increased from 372 to 521 per year. The occurrence of MH increased from 10.2 to 13.3 patients per million hospital discharges (P = 0.001). Mortality rates from MH ranged from 6.5% in 2005 to 16.9% in 2001 (P < 0.0001). The median age of patients with MH was 39 (interquartile range, 23-54 yr). Only 17.8% of the patients were children, who had lower mortality than adults (0.7% vs. 14.1%, P < 0.0001). Logistic regression analyses revealed that risk-adjusted in-hospital mortality was associated with increasing age, female sex, comorbidity burden, source of admission to hospital, and geographic region of the United States. Conclusions The incidence of MH in the United States has increased in recent years. The in-hospital mortality from MH remains elevated and higher than previously reported. The results of this study should enable the identification of areas requiring increased focus in MH-related education.

Inpatient burden of hidradenitis suppurativa in the United States: analysis of the 2016 National Inpatient Sample

2020 ◽  
pp. 1-3
Author(s):  
Raveena Khanna ◽  
Katherine A. Whang ◽  
Amy H. Huang ◽  
Kyle A. Williams ◽  
Rayva Khanna ◽  
...  
Keyword(s):  
United States ◽  
Hidradenitis Suppurativa ◽  
The United States ◽  
National Inpatient Sample

Limitation of Private Attending Pediatricians' Neonatal Intensive Care Privileges in Level III Institutions Throughout the United States

PEDIATRICS ◽  
1994 ◽  
Vol 94 (2) ◽  
pp. 190-193
Author(s):  
Rita G. Harper ◽  
Concepcion G. Sia ◽  
Regina Spinazzola ◽  
Raul A. Wapnir ◽  
Shahnaz Orner ◽  
...  
Keyword(s):  
United States ◽  
Intensive Care ◽  
Health Care Providers ◽  
Curriculum Design ◽  
Neonatal Intensive Care ◽  
District Of Columbia ◽  
The United States ◽  
Geographic Region ◽  
Neonatal Intensive Care Units ◽  
Care Providers

Objective. To determine the privileges of Private Attending Pediatricians (PAP) in caring for newborns requiring intensive (ITC), intermediate (IMC), or continuing (CC) care in Level III neonatal intensive care units (NICUs) throughout the United States. Design. A two-page mail questionnaire was sent to 429 Level III NICUs to obtain the statement best describing the PAPs' privileges, the number of PAP, and some of the PAPs' functions. Level III NICUs were classified by geographic region as Eastern, Central, or Western United States. Results. Responses were received from 301 NICUs (70%) representing 48 states, the District of Columbia, and >9000 PAP. Twenty-two institutions had no PAP. In the remaining 279 institutions, 96% (267/279) had restricted the PAPs' privileges partially or completely. In 32% (88/279), the PAP were not allowed to render any type of NICU care. In 18% (51/279) of the institutions, the PAP were allowed to render CC only. In 27% (76/279) of the institutions, the PAP were allowed to render IMC and CC only. Limitation of PAPs' privileges were reported in all geographic areas in the U.S., were more pronounced in the Eastern than the Central or Western sections of the country, and were noted in institutions with small (≤10) as well as large (≥60) numbers of PAP. Limitation of PAPs' privileges was determined by the PAP him/herself in many institutions. Proficiency in resuscitation was considered to be a needed skill. Communication with parents of an infant under the care of a neonatologist was encouraged. Conclusions. The PAPs' privileges were limited partially or completely in most Level III NICUs. Knowledge of this restricted role impacts significantly on curriculum design for pediatric house officers, number and type of health care providers required for Level III NICUs and future house officer's career choices.

Sign in / Sign up

Export Citation Format

Share Document